The Role of Liquid Biopsies in Tracking Tumor Evolution and Overcoming Therapeutic Resistance in Cancer
Oncology, Nuclear Medicine and Transplantology · 2025
DOI: 10.63946/onmt/17244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, Nuclear Medicine and Transplantology, 2025. Verfasst von Tosin Ayodeji Oladosu und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Liquid biopsies have developed as a revolutionary technique in cancer diagnosis, treatment evaluation, and the detection of therapeutic resistance. Unlike traditional tissue biopsies, which are invasive and limited to a single temporal analysis, liquid biopsies offer a non-invasive, real-time evaluation of tumour dynamics through the analysis of biomarkers such as circulating tumour DNA (ctDNA), circulating tumour cells (CTCs), exosomes, and microRNAs. This approach enables continuous monitoring of tumour advancement, allowing for the early detection of cancer, the tracking of minimal residual disease, and the identification of emerging resistance mutations. As cancers advance and acquire resistance to therapies, liquid biopsy provides critical information that enables clinicians to customise treatment strategies and improve outcomes. Despite challenges such as sensitivity limitations in early-stage cancers and the necessity for standardised testing protocols, technological advancements, including next-generation sequencing (NGS), CRISPR, and AI-driven analytics, are enhancing the precision and accessibility of liquid biopsies. Through ongoing validation and cost-reduction efforts, liquid biopsies are set to become essential to precision oncology, offering a transformative approach to cancer therapy that could improve patient outcomes and foster equitable healthcare globally.
Zitieren
APA
Oladosu, T. A., Okafor, C. P., Nwosu, P. C., Ibukunoluwa, A. E., Monica, U. I., & Aderanti, T. A. (2025). The Role of Liquid Biopsies in Tracking Tumor Evolution and Overcoming Therapeutic Resistance in Cancer. Oncology, Nuclear Medicine and Transplantology. https://doi.org/10.63946/onmt/17244
Vancouver
Oladosu TA, Okafor CP, Nwosu PC, Ibukunoluwa AE, Monica UI, Aderanti TA. The Role of Liquid Biopsies in Tracking Tumor Evolution and Overcoming Therapeutic Resistance in Cancer. Oncology, Nuclear Medicine and Transplantology. 2025. doi:10.63946/onmt/17244
BibTeX
@article{Oladosu2025,
author = {Oladosu, Tosin Ayodeji and Okafor, Chinaecherem Peace and Nwosu, Patrick Chinazam and Ibukunoluwa, Ayo Ebunolorun and Monica, Uduh Ifeoma and Aderanti, Tosin Abiodun},
title = {The Role of Liquid Biopsies in Tracking Tumor Evolution and Overcoming Therapeutic Resistance in Cancer},
journal = {Oncology, Nuclear Medicine and Transplantology},
year = {2025},
doi = {10.63946/onmt/17244}
}
EUVIMED